1.63
-0.08(-4.68%)
Currency In USD
| Previous Close | 1.71 |
| Open | 1.7 |
| Day High | 1.73 |
| Day Low | 1.62 |
| 52-Week High | 2.62 |
| 52-Week Low | 0.71 |
| Volume | 1.37M |
| Average Volume | 2M |
| Market Cap | 197.02M |
| PE | 2.96 |
| EPS | 0.55 |
| Moving Average 50 Days | 1.66 |
| Moving Average 200 Days | 1.28 |
| Change | -0.08 |
If you invested $1000 in Coherus Oncology, Inc. (CHRS) 10 years ago, it would be worth $111.64 as of February 21, 2026 at a share price of $1.63. Whereas If you bought $1000 worth of Coherus Oncology, Inc. (CHRS) shares 5 years ago, it would be worth $99.57 as of February 21, 2026 at a share price of $1.63.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
GlobeNewswire Inc.
Feb 17, 2026 9:11 PM GMT
–The Offering was led by healthcare-dedicated investors including Janus Henderson Investors, HBM Healthcare Investments and Samsara BioCapital– REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Compan
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
GlobeNewswire Inc.
Feb 13, 2026 2:18 AM GMT
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced the pricing of an underwritten public offering of 28,600,000 shares of the Company’s common stock (the “Offe
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced a proposed underwritten public offering of its common stock (the “Offering”). In addition, Coherus intends t